Clinical Trial Update: Metformin in Amnestic Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 trial investigating metformin in amnestic mild cognitive impairment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Columbia University | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2020-10-23